After battling with AstraZeneca over shipping delays and even questioning the effectiveness of its Covid-19 jab, EU countries are seeing the company’s gun stocks piling up – unused.
On Friday, France had administered 16% of the 1.1 million doses of the two-injection vaccine it had received since the first delivery in early February, according to the Ministry of Health. data. As of Thursday, Germany had administered just over a fifth of the 1.45 million doses, roughly the same proportion as Italy, which received more than a million doses. Spain used just under a third of a total of 808,000 doses on Friday.
The situation prompted several European leaders to denounce the …
Read Additional From Source
Copyright @ www.ft.com
News Highlights Finance
- Headline: AstraZeneca’s European stock rises as citizens snub their jab
- Check all news and articles from the Finance news updates.